The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin
Open accessAbstract
Hepatitis C virus (HCV) infects over 3% of the world population and is the leading cause of chronic liver disease worldwide. HCV has long been known to associate with circulating lipoproteins, and its interactions with the cholesterol and lipid pathways have been recently described. In this work, we demonstrate that HCV is actively secreted by infected cells through a Golgi-dependent mechanism while bound to very low density lipoprotein (vLDL). Silencing apolipoprotein B (ApoB) messenger RNA in infected cells causes a 70% reduction in the secretion of both ApoB-100 and HCV. More importantly, we demonstrate that the grapefruit flavonoid naringenin, previously shown to inhibit vLDL secretion both in vivo and in vitro , inhibits the microsomal triglyceride transfer protein activity as well as the transcription of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase and acyl-coenzyme A:cholesterol acyltransferase 2 in infected cells. Stimulation with naringenin reduces HCV secretion in infected cells by 80%. Moreover, we find that naringenin is effective at concentrations that are an order of magnitude below the toxic threshold in primary human hepatocytes and in mice. Conclusion: These results suggest a novel therapeutic approach for the treatment of HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Self-citationRobust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
Self-citationHepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor
Agnello, V., Ábel, G., Elfahal, M., Knight, G. B., & Zhang, Q.-X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12766 · Cited by 974
Hepatitis C virus replication in mice with chimeric human livers
Mercer, D. F., Schiller, D. E., Elliott, J. F., Douglas, D. N., Hao, C., Rinfret, A., Addison, W. R., Fischer, K. P., Churchill, T. A., Lakey, J. R. T., et al. (2001) · Nature Medicine · doi:10.1038/90968 · Cited by 901
Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism
Moon, Y. J., Wang, X., & Morris, M. E. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2005.06.048 · Cited by 869
Misumi, Y., Misumi, Y., Miki, K., Takatsuki, A., Tamura, G., & Ikehara, Y. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67398-3 · Cited by 847
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Barba, G., Harper, F., Harada, T., Kohara, M., Goulinet, S., Matsuura, Y., Eder, G., Schaff, Z., Chapman, M. J., Miyamura, T., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1200 · Cited by 658
Perlemuter, G., Sabile, A., Letteron, P., Vona, G., Topilco, A., Chrétien, Y., Koike, K., Pessayre, D., Chapman, J., Barba, G., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0396com · Cited by 584
Huang, H., Sun, F., Owen, D. M., Li, W., Chen, Y., Gale, M., & Ye, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700760104 · Cited by 533
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
Kapadia, S. B., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409834102 · Cited by 511
Dixon, J., & Ginsberg, H. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40744-8 · Cited by 368
Association of hepatitis C virus in human sera with ?-lipoprotein
Thomssen, R., Bonk, S., Propfe, C., Heermann, K.-H., K�chel, H. G., & Uy, A. (1992) · Medical Microbiology and Immunology · doi:10.1007/bf00198849 · Cited by 366
Jung, U. J., Kim, H. J., Lee, J. S., Lee, M. K., Kim, H. O., Park, E. J., Kim, H. K., Jeong, T. S., & Choi, M. S. (2003) · Clinical Nutrition · doi:10.1016/s0261-5614(03)00059-1 · Cited by 257
Wilcox, L. J., Borradaile, N. M., de Dreu, L. E., & Huff, M. W. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31634-5 · Cited by 254
Lee, C.-H., Jeong, T.-S., Choi, Y.-K., Hyun, B.-H., Oh, G.-T., Kim, E.-H., Kim, J.-R., Han, J.-I., & Bok, S.-H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5001 · Cited by 254
Gastaminza, P., Kapadia, S. B., & Chisari, F. V. (2006) · Journal of Virology · doi:10.1128/jvi.01150-06 · Cited by 241
Kanno, S.-I., Tomizawa, A., Hiura, T., Osanai, Y., Shouji, A., Ujibe, M., Ohtake, T., Kimura, K., & Ishikawa, M. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.527 · Cited by 233
Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction
Barth, H., Schnober, E. K., Zhang, F., Linhardt, R. J., Depla, E., Boson, B., Cosset, F.-L., Patel, A. H., Blum, H. E., & Baumert, T. F. (2006) · Journal of Virology · doi:10.1128/jvi.00941-06 · Cited by 192
Hepatitis C Virus Particles and Lipoprotein Metabolism
André, P., Perlemuter, G., Budkowska, A., Bréchot, C., & Lotteau, V. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-864785 · Cited by 180
Sabile, A., Perlemuter, G., Bono, F., Kohara, K., Demaugre, F., Kohara, M., Matsuura, Y., Miyamura, T., Bréchot, C., & Barba, G. (1999) · Hepatology · doi:10.1002/hep.510300429 · Cited by 173
Maillard, P., Huby, T., Andréo, U., Moreau, M., Chapman, J., & Budkowska, A. (2006) · The FASEB Journal · doi:10.1096/fj.05-4728fje · Cited by 158
Allister, E. M., Borradaile, N. M., Edwards, J. Y., & Huff, M. W. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1676 · Cited by 116
Hypocholesterolemic effects of dietary citrus juices in rabbits
Kurowska, E. M., Borradaile, N. M., Spence, J. D., & Carroll, K. K. (2000) · Nutrition Research · doi:10.1016/s0271-5317(99)00144-x · Cited by 114
Borradaile, N. M., de Dreu, L. E., Barrett, P. H. R., Behrsin, C. D., & Huff, M. W. (2003) · Biochemistry · doi:10.1021/bi026731o · Cited by 106
Nahmias, Y., Casali, M., Barbe, L., Francois Berthiaume, B., & Yarmush, M. L. (2006) · Hepatology · doi:10.1002/hep.21016 · Cited by 80
Self-citationInhibition of hepatocyte apoB secretion by naringenin
Borradaile, N. M., de Dreu, L. E., Barrett, P. H. R., & Huff, M. W. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200115-jlr200 · Cited by 79
Kim, S.-Y., Kim, H.-J., Lee, M., Jeon, S.-M., Do, G., Kwon, E., Cho, Y.-Y., Kim, D., Jeong, K., Park, Y. B., et al. (2006) · Journal of Medicinal Food · doi:10.1089/jmf.2006.9.582 · Cited by 73
Hepatitis C Virus Nonstructural Proteins Inhibit Apolipoprotein B100 Secretion
Domitrovich, A. M., Felmlee, D. J., & Siddiqui, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510391200 · Cited by 70
Huong, D. T. T., Takahashi, Y., & Ide, T. (2006) · Nutrition · doi:10.1016/j.nut.2005.11.006 · Cited by 68
Monazahian, M., Kippenberger, S., Müller, A., Seitz, H., Böhme, I., Grethe, S., & THOMSSEN, R. (2000) · Medical Microbiology and Immunology · doi:10.1007/s004300000032 · Cited by 67
Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo
Deforges, S., Evlashev, A., Perret, M., Sodoyer, M., Pouzol, S., Scoazec, J., Bonnaud, B., Diaz, O., Paranhos‐Baccalà, G., Lotteau, V., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.80071-0 · Cited by 63
Cited by
The Therapeutic Potential of Naringenin: A Review of Clinical Trials
Salehi, B., Fokou, P. V. T., Sharifi-Rad, M., Zucca, P., Pezzani, R., Martins, N., & Sharifi-Rad, J. (2019) · Pharmaceuticals · doi:10.3390/ph12010011 · Cited by 814
A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models
Ding, Q., Lee, Y.-K., Schaefer, E. A. K., Peters, D. T., Veres, A., Kim, K., Kuperwasser, N., Motola, D. L., Meissner, T. B., Hendriks, W. T., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.11.011 · Cited by 501
Self-citationAntiviral activities of flavonoids
Badshah, S. L., Faisal, S., Muhammad, A., Poulson, B. G., Emwas, A. H., & Jaremko, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111596 · Cited by 406
Zumla, A., Rao, M., Wallis, R. S., Kaufmann, S. H. E., Rustomjee, R., Mwaba, P., Vilaplana, C., Yeboah-Manu, D., Chakaya, J., Ippolito, G., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00078-5 · Cited by 402
The ins and outs of hepatitis C virus entry and assembly
Lindenbach, B. D., & Rice, C. M. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3098 · Cited by 387
Metadata
- Authors
- Nahmias, Y., Goldwasser, J., Casali, M., van Poll, D., Wakita, T., Chung, R. T., & Yarmush, M. L.
- Venue
- Hepatology
- Published
- 2008-05
- Volume
- 47
- Issue
- 5
- Pages
- 1437-1445
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1970828145
- Cited by
- 279
- References
- 33
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.